← Back to Search

Smartwatch Monitoring for Respiratory Diseases

N/A

Recruiting

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will study how a smartwatch device can help monitor and detect respiratory disease flare-ups, offering people with the disease more freedom and better care.

Who is the study for?

This trial is for adults over 18 fluent in English with lung diseases like COPD, interstitial lung disease, or pulmonary hypertension. Healthy individuals can also join. Participants must be able to use the Health Gauge wearable device and sign consent. Excluded are pregnant individuals, those with electronic implants, significant daily living activity impairment, skin issues near sensor sites, or allergies to plastic.Check my eligibility

What is being tested?

The study tests the Health Gauge Phoenix AI-based Smart Watch's ability to monitor vital signs and physical activities continuously at home. It aims to prove long-term comfort of use, safety, and potential in detecting exacerbations earlier than current methods.See study design

What are the potential side effects?

Since this trial involves a non-invasive wearable device monitoring health parameters without medications or invasive procedures involved, side effects may include discomfort from wearing the device or skin irritation at the site of application.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Length of time wearing device

Secondary outcome measures

Adverse Events

Prediction of respiratory exacerbations- Number of emergency room visits or hospitalizations

Trial Design

1Treatment groups

Experimental Treatment

Group I: Device: Health Gauge AI-Based Wearable Device - Model: PhoenixExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

889 Previous Clinical Trials

385,137 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an opportunity for individuals to enroll in this experiment?

"Clinicaltrials.gov displays that this research project, first posted on October 11th 2023, is actively searching for participants. The trial details were most recently modified on the 24th of October 2023."

Answered by AI

To what scale is the research of this trial being conducted?

"Affirmative. Clinicaltrials.gov provides evidence that recruitment for this medical research project is in full swing, having first been posted on October 11th 2023 and last updated on the 24th of the same month. For now 40 patients are being sought from a single site to participate in this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Integrating ePReBMs From Phoenix in Respiratory Diseases

2023. "Integrating ePReBMs From Phoenix in Respiratory Diseases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05827302.

All > Interstitial Lung Disease > Pulmonary Hypertension